Scientific Considerations for Evaluating Cancer Bioassays Conducted by the Ramazzini Institute | Zendy

Jeffrey S. Gift | Zendy; Jane C. Caldwell | Zendy; Jennifer Jinot | Zendy; Marina V. Evans | Zendy; Ila Cote | Zendy; John J. Vandenberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Scientific Considerations for Evaluating Cancer Bioassays Conducted by the Ramazzini Institute

Author(s) -

Jeffrey S. Gift,

Jane C. Caldwell,

Jennifer Jinot,

Marina V. Evans,

Ila Cote,

John J. Vandenberg

Publication year - 2013

Publication title -

environmental health perspectives

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.257

H-Index - 282

eISSN - 1552-9924

pISSN - 0091-6765

DOI - 10.1289/ehp.1306661

Subject(s) - lymphoma , medicine , context (archaeology) , medical diagnosis , cancer , leukemia , pathology , oncology , biology , paleontology

The Ramazzini Institute (RI) has completed nearly 400 cancer bioassays on > 200 compounds. The European Food Safety Authority (EFSA) and others have suggested that study design and protocol differences between the RI and other laboratories by may contribute to controversy regarding cancer hazard findings, principally findings on lymphoma/leukemia diagnoses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research